tx-July102026-51: 22 TAC §§173.6 - 173.17 — Office-based Anesthesia Services
Public comment closed .
Get alerted when the next rule lands
New rules open for comment on their own schedule. Pick how you want to hear about them — we email you when one appears.
Publishing to members? Embed a live rule tracker on your own site — the proposed rules in your area and the comment deadlines closing on them, updating themselves. Free, one line of HTML.
Create a free account & build one →Summary
The Texas Medical Board (Board) proposes Chapter 173, Office-Based Anesthesia Services, new Subchapter B, titled Parenteral Ketamine Therapy, §§173.6 - 173.17. The proposed new sections are as follows: New §173.6, Definitions, sets forth definitions for "administration of ketamine", "adverse event", "initial dose", "medical director", "PKT practice", "psychotropic ketamine therapy (PKT)" and "practitioner." New §173.7, Mandatory Registration, mandates registration for PKT Practices and sets forth an application procedure. The section further proposes a 180-day grace period for implementation of the requirements set forth under Chapter 173, Subchapter B, except for adverse reporting requirements under New §173.14, which must be met upon the effective date of the rule's adoption. New §173.8, Exemptions from Registration, sets forth practice settings exempt from required registration and the rules promulgated under new Subchapter B. New §173.9, Renewal of PKT Practice Registration, proposes a two-year registration term and sets forth registration renewal requirements. New §173.10, Medical Director Requirements, sets forth medical director eligibility requirements, duties, and...
The agency’s own summary, as published.
Don't miss the comment window
One Click Politics alerts you on every deadline, hearing, and rule change.
See all rules with comments due soon →